The treatment of advanced melanoma: Current approaches and new challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The treatment of advanced melanoma: Current approaches and new challenges

Published:2024-04 Issue: Volume:196 Page:104276
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Boutros Andrea^ORCID,Croce Elena,Ferrari Marco,Gili Riccardo,Massaro Giulia,Marconcini Riccardo,Arecco Luca,Tanda Enrica Teresa,Spagnolo Francesco

Publisher

Elsevier BV

Reference102 articles.

1. Genomic classification of cutaneous melanoma;Akbani;Cell,2015

2. Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies;Algazi;Cancer,2016

3. Phase II LEAP-004 study of lenvatinib plus pembrolizumab for melanoma with confirmed progression on a programmed cell death protein-1 or programmed death ligand 1 inhibitor given as monotherapy or in combination;Arance;J. Clin. Oncol.,2023

4. Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial;Ascierto;Lancet Oncol.,2016

5. Survival outcomes in patients with previously untreated BRAF wild-type advanced melanoma treated with nivolumab therapy: three-year follow-up of a randomized phase 3 trial;Ascierto;JAMA Oncol.,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early versus late response to PD-1-based immunotherapy in metastatic melanoma;European Journal of Cancer;2024-10

2. Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies;Cancers;2024-08-16

3. Approaches to the treatment of oligometastatic melanoma in the era of immunotargeted therapy;Meditsinskiy sovet = Medical Council;2024-07-23

4. Silencing Exosomal circ102927 Inhibits Foot Melanoma Metastasis via Regulating Invasiveness, Epithelial-Mesenchymal Transition and Apoptosis;Cancer Management and Research;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3